Human Longevity Inc. (HLI) said today it has acquired Cypher Genomics for an undisclosed price, in a deal that adds human genomic interpretation software solutions to the buyer’s offerings.

Located in San Diego, Cypher Genomics is a genetic information company developing and operating a software named Mantis™ aims to discover the clinical significant variants rapidly for customers. And also it  developed Coral™, a biomarker discovery service.

“We developed Mantis and Coral to provide rapid, automated, genome interpretation at scale enabling disease gene identification, population-based studies, diagnostic development, and biomarker identification," Cypher CEO and co-founder Ashley Van Zeeland, Ph.D., said in a statement.

For those software products, Cypher Genomics has collaborated with industry partners that include Celgene, Illumina, and Sequenom. Cypher has also established collaborations with academic institutions such as Scripps Translational Science Institute, University of Pennsylvania, and Clinic for Special Children.

"We look forward to joining the HLI team and to helping advance HLI's mission of applying the power of human genomics and informatics to improve healthcare," Dr. Van Zeeland added.